Generation Bio (GBIO) director McDonough reports RSU vesting and share sale
Rhea-AI Filing Summary
Generation Bio Co. director Geoff McDonough reported equity activity tied to restricted stock units on February 2, 2026. A total of 1,582 restricted stock units vested and converted into the same number of common shares at an exercise price of $0, increasing his direct common stock holdings.
To cover tax obligations from this vesting, 550 common shares were disposed of at $5.64 per share, leaving McDonough with 138,492 common shares held directly. He also has indirect beneficial ownership of 22,646 shares through the McDonough Family 2018 Irrevocable Trust and 27,500 shares through the McDonough Family 2020 Irrevocable Trust.
The vested units come from a grant of 8,437 restricted stock units awarded on January 20, 2023, which became fully vested on February 2, 2026 under the terms of a merger agreement among Generation Bio, XOMA Royalty Corporation and a subsidiary.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,582 | $0.00 | -- |
| Exercise | Common Stock | 1,582 | $0.00 | -- |
| Tax Withholding | Common Stock | 550 | $5.64 | $3K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Each restricted stock unit represents the right to receive one share of the company's common stock. The securities are directly held by the McDonough Family 2018 Irrevocable Trust, or the 2018 Trust. The reporting person is the settlor of the 2018 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2018 Trust, and the 2018 Trust is for the benefit of Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2018 Trust. The securities are directly held by the McDonough Family 2020 Irrevocable Trust, or the 2020 Trust. The reporting person is the settlor of the 2020 Trust, Allison L. McDonough and David S. Grayzel are trustees for the 2020 Trust, and the 2020 Trust is for the benefit of Allison, Graeme and Owen McDonough. The reporting person may be deemed to beneficially own the shares of common stock owned by the 2020 Trust. On January 20, 2023, the reporting person was granted 8,437 restricted stock units. Pursuant to the terms of that certain Agreement and Plan of Merger, by and among the Issuer, XOMA Royalty Corporation ("Parent") and Parent's wholly-owned subsidiary, XRA 7 Corp., dated as of December 15, 2025 (the "Merger Agreement"), prior to the effective time of the merger as contemplated by the Merger Agreement, each restricted stock unit of the Issuer that was outstanding and unvested became vested in full on February 2, 2026.
